Other languages Protagenic Therapeutics, Inc.

Equities

PTIX

US74365N2027

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-24 pm EDT			5-day change	1st Jan Change
1.56 ^USD	-6.59%		+3.99%	+57.58%

May. 01	Protagenic Therapeutics, Inc. Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial	CI
Apr. 01	Protagenic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Protagenic Therapeutics, Inc. Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial	May. 01
Protagenic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01
Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders	Mar. 27
Protagenic Therapeutics Achieves First Clinical Safety Milestone with Its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders	Feb. 13
Wall Street Set to Open Slightly Higher Tuesday; Annual Inflation Declines to 3.1%	Dec. 12
Protagonist Therapeutics, Inc. Reports 2-Year Follow Up Data from Rusfertide REVIVE Study at the ASH Annual Meeting Showing Durable Efficacy and No New Safety Signals	Dec. 12
Protagenic Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Protagenic Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Protagenic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31
Protagenic Therapeutics, Inc. Appoints Timothy R. Wright as a Class I Director	22-11-29
Protagenic Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Protagenic Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11
Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13
Protagenic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-07
Protagenic Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15
Protagenic Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16
Protagenic Therapeutics : Expects to Refile New Drug Application in Q4 After Implementing Change Requested by FDA	21-07-23
Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17
Protagenic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Protagenic Therapeutics, Inc.

Equities

PTIX

US74365N2027

Other languages

Filters